The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...

Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...

Equities researchers at Leerink Partnrs lifted their Q3 2025 earnings estimates for Cencora in a research report issued on ...

Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages. This marks ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on COR stock, giving a Buy rating on January 14.Invest with ...

Shares of Cencora, Inc. (NYSE:COR – Get Free Report) reached a new 52-week high on Wednesday after the company announced ...

Cencora COR underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on ...

2. Potential disintermediation in Centene (NYSE:CNC)'s (CI) specialty relationship: Any disruption in this partnership could affect Cencora's market position. 3. Retail channel volatility: Store ...

3. Retail channel volatility: Store closings by major pharmacy chains could impact Cencora's distribution volumes. 4. NADAC (National Average Drug Acquisition Cost) volatility: Fluctuations in ...